Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2/3 1Phase 2 1

Status

Completed 136Terminated 58Recruiting 38Active not recruiting 21Unknown 16Withdrawn 14Not yet recruiting 4Suspended 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 1

Conditions

Breast Neoplasms 11Lymphoma, Large B-Cell, Diffuse 10Triple Negative Breast Neoplasms 8Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, B-Cell 6Neoplasm Metastasis 4Multiple Myeloma 4Leukemia, Myeloid, Acute 4Leukemia 4Neuroblastoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Graft vs Host Disease 3Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Neoplasms, Plasma Cell 2Lymphoma, Follicular 2Hodgkin Disease 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Renal Cell 2Brain Neoplasms 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1

Interventions

venetoclax 26Azacitidine 24fludarabine 11Cytarabine 11Specimen Handling 9Biopsy 7Busulfan 6Melphalan 5Decitabine 5Daunorubicin 5Thiotepa 4Cyclophosphamide 4selinexor 3olutasidenib 3gilteritinib 3Whole-Body Irradiation 3Tacrolimus 3Idarubicin 3Homoharringtonine 3treosulfan 2revumenib 2fludarabine phosphate 2decitabine and cedazuridine drug combination 2Stem Cell Transplantation 2Maintenance 2Lymphatic Irradiation 2Leukapheresis 2Injections 2Granulocyte Colony-Stimulating Factor 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Leukemia, Myeloid, Acute × Cyclophosphamide × Clear all
NCT07583303 2026-05-13

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

City of Hope Medical Center

Phase 1 Not yet recruiting
19 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07548983 2026-04-23

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

OHSU Knight Cancer Institute

Phase 1 Not yet recruiting
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05565105 2026-03-03

CD34+ Transplants for Leukemia and Lymphoma

Baptist Health South Florida

Phase 2 Not yet recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07157514 2025-09-10

Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

Actinium Pharmaceuticals

Phase 2/3 Not yet recruiting
306 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡